NAD<sup>+</sup> improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway.
Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J. · 2021
Read NAD<sup>+</sup> improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway. by Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8444613.txt.
Description
Zhao and co-authors test NAD+ as a guard for the brain in rats with chronic low blood flow. Poor brain blood flow feeds vascular dementia through microglia-driven inflammation. NAD+ had shown anti-inflammatory and antioxidant effects in other brain disease models, but not in this one.
Rats with blocked carotid arteries got daily NAD+ shots for 8 weeks. The treatment rescued learning and memory performance. It calmed brain inflammation by shielding mitochondria and cutting reactive oxygen output. Gene scans pointed to the Sirt1 and PGC-1alpha pathway. Cell tests with extra Sirt1 backed the finding. The work ties NAD+ gains to healthier mitochondria in microglia.
Catalog record
| CREATOR | Zhao Y, Zhang J, Zheng Y, Zhang Y, Zhang XJ, Wang H, Du Y, Guan J, Wang X, Fu J. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |